229 related articles for article (PubMed ID: 23648086)
21. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.
Leggio L; Cardone S; Ferrulli A; Kenna GA; Diana M; Swift RM; Addolorato G
Curr Pharm Des; 2010; 16(19):2159-18. PubMed ID: 20482506
[TBL] [Abstract][Full Text] [Related]
22. Translational models of interactions between stress and alcohol consumption: strengths and limitations.
Hopf FW; Sparta DR; Bonci A
ILAR J; 2011; 52(3):239-50. PubMed ID: 23382142
[TBL] [Abstract][Full Text] [Related]
23. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.
Cannella N; Ubaldi M; Masi A; Bramucci M; Roberto M; Bifone A; Ciccocioppo R
Neurosci Biobehav Rev; 2019 Aug; 103():384-398. PubMed ID: 31112713
[TBL] [Abstract][Full Text] [Related]
24. A neuropeptide-centric view of psychostimulant addiction.
Boutrel B
Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
[TBL] [Abstract][Full Text] [Related]
25. Alcoholism and neuropeptides: an update.
Cowen MS; Lawrence AJ
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
[TBL] [Abstract][Full Text] [Related]
26. An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism.
Becker HC; Lopez MF
Int Rev Neurobiol; 2016; 126():157-77. PubMed ID: 27055614
[TBL] [Abstract][Full Text] [Related]
27. Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism.
Reilly MT; Noronha A; Warren K
Handb Clin Neurol; 2014; 125():15-29. PubMed ID: 25307566
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats.
Caputi FF; Stopponi S; Rullo L; Palmisano M; Ubaldi M; Candeletti S; Ciccocioppo R; Romualdi P
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671048
[TBL] [Abstract][Full Text] [Related]
29. How do we 'learn' addiction? Risk factors and mechanisms getting addicted to alcohol.
Hägele C; Friedel E; Kienast T; Kiefer F
Neuropsychobiology; 2014; 70(2):67-76. PubMed ID: 25359487
[TBL] [Abstract][Full Text] [Related]
30. Application of human laboratory models to pharmacotherapy development for alcohol dependence.
Ray LA; Hutchison KE; Tartter M
Curr Pharm Des; 2010; 16(19):2149-58. PubMed ID: 20482505
[TBL] [Abstract][Full Text] [Related]
31. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
Valdez GR; Koob GF
Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
[TBL] [Abstract][Full Text] [Related]
32. Recent animal models of alcoholism.
Spanagel R
Alcohol Res Health; 2000; 24(2):124-31. PubMed ID: 11199279
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years.
Blanco-Gandía MC; Rodríguez-Arias M
Eur J Pharmacol; 2018 Oct; 836():89-101. PubMed ID: 30096298
[TBL] [Abstract][Full Text] [Related]
34. New insights on neurobiological mechanisms underlying alcohol addiction.
Cui C; Noronha A; Morikawa H; Alvarez VA; Stuber GD; Szumlinski KK; Kash TL; Roberto M; Wilcox MV
Neuropharmacology; 2013 Apr; 67():223-32. PubMed ID: 23159531
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
Neurotox Res; 2016 Jan; 29(1):173-96. PubMed ID: 26353844
[TBL] [Abstract][Full Text] [Related]
36. Proteomic approaches and identification of novel therapeutic targets for alcoholism.
Gorini G; Harris RA; Mayfield RD
Neuropsychopharmacology; 2014 Jan; 39(1):104-30. PubMed ID: 23900301
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation and brain gene expression in rodent models of alcoholism implications for medication development.
Björk K; Hansson AC; Sommer WH
Int Rev Neurobiol; 2010; 91():129-71. PubMed ID: 20813242
[TBL] [Abstract][Full Text] [Related]
38. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
Rudzińska U; Zalewska-Kaszubska J
Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic treatment of alcoholism.
Anton RF; Schacht JP; Book SW
Handb Clin Neurol; 2014; 125():527-42. PubMed ID: 25307594
[TBL] [Abstract][Full Text] [Related]
40. New horizons for therapeutics in drug and alcohol abuse.
Jupp B; Lawrence AJ
Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
